Clinical Trials on Malignant Melanoma Stage III in Germany
Total 115 results
-
Dermatologic Cooperative Oncology GroupUnknownTherapy | Adjuvant | Stage III Malignant Melanoma | Interferon AlphaGermany
-
University Hospital TuebingenCompletedLocoregional Metastases in Malignant Melanoma Stages IIIB/CGermany
-
University Hospital TuebingenUnknownMalignant Melanoma Stage IVGermany
-
Pierre Fabre Pharma GmbHPierre Fabre Pharma Austria; Pierre Fabre Pharma AGRecruitingMelanoma Stage IV | Melanoma Stage IIIAustria, Germany, Switzerland
-
OncoHost Ltd.RecruitingStage IV Non-small Cell Lung Cancer | Stage III Malignant Melanoma | Stage IV Small Cell Lung Cancer | Stage IV Malignant MelanomaUnited States, Israel, United Kingdom, Germany, Spain
-
Eisai Inc.CompletedStage IV Melanoma | Unresectable Stage IIIUnited States, United Kingdom, Australia, Germany
-
University Hospital, EssenActive, not recruitingMalignant Melanoma Stage IIGermany
-
Daiichi Sankyo, Inc.PlexxikonTerminatedV600-mutated BRAF Unresectable Melanoma | V600-mutated BRAF Metastatic Melanoma | Stage III or Stage IV Metastatic Melanoma That Has Not Been Previously Treated With a Selective BRAF InhibitorUnited States, Germany, France
-
BioNTech SERegeneron PharmaceuticalsActive, not recruitingUnresectable Melanoma | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, Italy, Australia, United Kingdom, Poland
-
European Organisation for Research and Treatment...Active, not recruitingStage IV Melanoma | Unresectable Stage III MelanomaFrance, Denmark, Spain, Finland, Italy, Germany, Poland, United Kingdom, Netherlands
-
Fachklinik Hornheide an der Universität MünsterWestfälische Wilhelms-Universität Münster; Deutsche RentenversicherungCompletedQuality of Life | Work Ability | Malignant Melanoma of SkinGermany
-
University Hospital TuebingenCompleted
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsBelgium, Spain, Germany, Netherlands, Finland
-
University Hospital TuebingenGerman Research FoundationCompleted
-
University Hospital TuebingenCompletedMalignant MelanomaGermany
-
Nektar TherapeuticsBristol-Myers SquibbTerminatedMelanoma | Melanoma (Skin) | Melanoma Stage IV | Melanoma Stage IIIUnited States, Spain, Germany, France, Australia, Italy, Greece, Israel, Russian Federation, New Zealand, Austria, United Kingdom, Netherlands, Portugal, Poland, Czechia, Romania
-
Hoffmann-La RocheCompletedMalignant Melanoma, NeoplasmsSpain, New Zealand, Hungary, Serbia, Germany, Portugal, Netherlands, Greece, Australia
-
Ruhr University of BochumCompletedCutaneous Malignant MelanomaGermany
-
Ruhr University of BochumCompleted
-
Bristol-Myers SquibbCompletedHigh Risk Stage III MelanomaItaly, Poland, United Kingdom, United States, Netherlands, Spain, Australia, France, Germany, Canada, Russian Federation, Belgium, Norway, Switzerland, Sweden, Finland, Austria, Denmark, Czechia
-
University Hospital MuensterUnknown
-
4SC AGCompletedMalignant MelanomaGermany, Italy
-
Philogen S.p.A.CompletedMalignant MelanomaAustria, Germany
-
University Hospital FreiburgUniversitätsklinikum Köln; Essex Pharma GmbHUnknownMalignant MelanomaGermany
-
Philogen S.p.A.Active, not recruiting
-
AmgenCompletedUnresected Stage IIIb to IVM1c MelanomaFrance, Poland, Italy, Russian Federation, Netherlands, Spain, United States, Austria, Belgium, United Kingdom, Germany, Hungary, Greece
-
Fachklinik Hornheide an der Universität MünsterUnknownAdvanced Metastastic Malignant Melanoma | Refractory to First-Line Chemotherapy Irresectable Progressive Soft Tissue MetastasesGermany
-
Prof. Dr. med. Dirk SchadendorfBoehringer Ingelheim; medac GmbH; Alcedis GmbHCompletedCutaneous Malignant MelanomaGermany
-
University Hospital TuebingenTerminatedMalignant MelanomaGermany, France
-
Prof. Dr. med. Dirk SchadendorfTerminatedMalignant MelanomaGermany
-
University Hospital, BonnMundipharma Research GmbH & Co KGTerminatedLeptomeningeal Metastasis From Malignant MelanomaGermany
-
Prof. Dr. med. Dirk SchadendorfCompletedMalignant MelanomaGermany
-
Novo Nordisk A/STerminatedCancer | Malignant MelanomaGermany
-
Prof. Dr. med. Dirk SchadendorfCompleted
-
University Hospital HeidelbergDietmar Hopp StiftungRecruitingNSCLC Stage IIIB | NSCLC Stage II | NSCLC, Stage IIIAGermany
-
Technische Universität DresdenTerminatedBrain Metastases | Malignant Melanoma Stage IV | BRAF V600 MutationGermany
-
Bristol-Myers SquibbTerminatedMalignant MelanomaGermany, United States, Mexico, Denmark, France, Belgium, United Kingdom, Spain
-
sigma-tau i.f.r. S.p.A.CompletedMalignant MelanomaFrance, Germany, Hungary, Italy, Poland, Portugal, Spain, Switzerland
-
Eisai Inc.Quintiles, Inc.CompletedStage IV MelanomaUnited Kingdom, United States, Spain, Germany, Italy
-
Hoffmann-La RocheTerminatedMalignant MelanomaUnited States, France, Australia, United Kingdom, Italy, Spain, Germany, Israel, Poland, Slovakia
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, United Kingdom, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand
-
CancerVax CorporationUnknownMalignant MelanomaUnited States, France, Australia, Canada, Germany, Switzerland, Brazil, Ireland, Israel, Italy, Netherlands, New Zealand, United Kingdom
-
Hoffmann-La RocheCompletedMalignant MelanomaFrance, Germany, Italy, Sweden, United States, Australia, Canada, United Kingdom, Netherlands, Switzerland, New Zealand, Israel
-
Hoffmann-La RocheCompletedMalignant MelanomaItaly, United Kingdom, Belgium, Poland, Netherlands, Germany, Austria, Czechia, Ireland, Sweden
-
Hoffmann-La RocheCompletedMalignant MelanomaCanada, Spain, United Kingdom, Hungary, Australia, Austria, Belgium, Ecuador, Estonia, Finland, Ireland, Italy, Korea, Republic of, Mexico, Netherlands, Portugal, Slovenia, Sweden, Turkey, Brazil, India, Germany, Bosnia and Herzegovina and more
-
CelgeneUniversity of ArizonaCompletedMalignant MelanomaCanada, United States, Australia, United Kingdom, France, Italy, Spain, Germany, Netherlands
-
Hoffmann-La RocheCompletedMalignant MelanomaUnited States, Spain, Hungary, Israel, United Kingdom, Australia, Austria, Belgium, Czechia, France, Germany, Italy, Netherlands, Russian Federation, Sweden, Switzerland, Canada, New Zealand, Norway
-
University Hospital TuebingenRecruitingRectal Cancer | Rectal Neoplasms | Rectal Cancer Stage II | Rectal Cancer Stage IIIGermany
-
Johannes Gutenberg University MainzCompletedRectal Cancer Stage II | Rectal Cancer Stage IIIGermany